Blastocystis hominis | |
---|---|
Scientific classification | |
Domain: | Eukaryota |
Clade: | Diaphoretickes |
Clade: | SAR |
Clade: | Stramenopiles |
Phylum: | Bigyra |
Class: | Blastocystea |
Order: | Blastocystida |
Family: | Blastocystidae |
Genus: | Blastocystis |
Species: | B. hominis |
Binomial name | |
Blastocystis hominis | |
Blastocystis hominis is a single-celled eukaryotic organism that inhabits the gastrointestinal tract of humans and various animals. [1] This stramenopile exhibits significant genetic diversity and has become an organism of increasing scientific interest due to its widespread distribution and controversial role in human health. [2] Recent molecular studies have identified numerous subtypes, suggesting a complex evolutionary history and host-parasite relationship. [3] The organism is one of the most common intestinal protists in humans, with infection rates reaching up to 100% in some developing regions. [4] While commonly referred to as Blastocystis hominis in humans, the current taxonomic convention recognizes various species and subtypes within the genus Blastocystis , with at least 17 different subtypes identified through molecular analysis. [5]
Blastocystis hominis was initially misidentified as a yeast in the early 20th century and has undergone several taxonomic reclassifications. [6] Alexeieff (1911) initially classified it as a flagellate cyst, but Brumpt (1912) later established it as a distinct organism. [7] Modern molecular phylogenetic analyses have definitively assigned it to Stramenopiles, a diverse group of predominantly photosynthetic organisms. [8] Genetic studies have identified several subtypes, each with different host specificities and potential pathogenic abilities [9]
Blastocystis hominis demonstrates tremendous morphological plasticity throughout its life cycle. [11] The vacuolar form, which is most usually seen in laboratory cultures, has a large central vacuole surrounded by peripheral cytoplasm containing the nucleus and other organelles. [12] The granular form appears similar, but it has discrete granules within the central vacuole, which could represent metabolic products or reproductive elements. [13] The amoeboid type has an irregular shape with pseudopod-like extensions and is commonly seen in symptomatic patients. [14] Recent electron microscopy studies have shown sophisticated interior features, such as surface coat variations and organelles that resemble mitochondrion [15]
Blastocystis hominis has a multistage life cycle and is highly adaptable to a variety of host environments. [16] The illness develops when the cyst form is consumed by contaminated food or water. [17] When the cyst enters the colon, it grows into a vacuolar form, which is the key diagnostic stage usually seen in stool samples. [18]
The organism has two separate transmission patterns: external transmission and self-infection. During external transmission, thick-walled cysts discharged in feces can survive in the environment and stay infectious for long periods. [19] These environmentally resistant cysts enhance transmission between hosts via the fecal-oral pathway. [20]
In autoinfection, thin-walled cysts form from the vacuolar form and excyst within the intestine, sustaining infection in the same host. [6] The vacuolar shape can also transform into a multi-vacuolar. It may eventually transform into an amoeboid. The amoeboid stage, while less prevalent, is thought to play a role in pathogenicity. [21]
Binary fission is the principal mode of reproduction, occurring in both vacuolar and amoeboid forms. [22] Under stress conditions, such as unfavorable environmental factors or host immunological responses, the organism can generate pre-cyst stages that eventually develop into mature cysts. [23] This complicated life cycle, with its numerous physical forms, helps the organism colonize and spread to a wide range of host species. [24]
There is still disagreement among scientists on Blastocystis hominis's capacity for pathogenicity. [24] Abdominal pain, recurrent diarrhea, and irritable bowel syndrome (IBS) are among the often reported clinical symptoms. [25] The existence of the organism in a large number of asymptomatic people, however, makes it more difficult to comprehend its potential for pathogenicity. [26] Current diagnostic techniques have progressed from basic microscopy to include molecular tools such as PCR-based techniques, [27] since studies have indicated possible links between Blastocystis infections [28] and changes in the gut microbiota. [29]
Giardia duodenalis, also known as Giardia intestinalis and Giardia lamblia, is a flagellated parasitic protozoan microorganism of the genus Giardia that colonizes the small intestine, causing a diarrheal condition known as giardiasis. The parasite attaches to the intestinal epithelium by a ventral disc, and reproduces via binary fission. G. duodenalis is a non-invasive parasite, that does not spread to other parts of the gastrointestinal tract, but remains confined to the lumen of the small intestine. The parasite exists in two forms; trophozoites and cysts. The microorganism can undergo encystation, transforming into a dormant cyst that enables it to survive outside of its host. Giardia trophozoites are anaerobic, and absorb their nutrients from the intestinal lumen. If the organism is stained, its characteristic pattern resembles the familiar "smiley face" symbol.
Trichomonas vaginalis is an anaerobic, flagellated protozoan parasite and the causative agent of a sexually transmitted disease called trichomoniasis. It is the most common pathogenic protozoan that infects humans in industrialized countries. Infection rates in men and women are similar but women are usually symptomatic, while infections in men are usually asymptomatic. Transmission usually occurs via direct, skin-to-skin contact with an infected individual, most often through vaginal intercourse. It is estimated that 160 million cases of infection are acquired annually worldwide. The estimates for North America alone are between 5 and 8 million new infections each year, with an estimated rate of asymptomatic cases as high as 50%. Usually treatment consists of metronidazole and tinidazole.
Mycoplasma hominis is a species of bacteria in the genus Mycoplasma. M. hominis has the ability to penetrate the interior of human cells. Along with ureaplasmas, mycoplasmas are the smallest free-living organisms known.
Entamoeba coli is a non-pathogenic species of Entamoeba that frequently exists as a commensal parasite in the human gastrointestinal tract. E. coli is important in medicine because it can be confused during microscopic examination of stained stool specimens with the pathogenic Entamoeba histolytica. This amoeba does not move much by the use of its pseudopod, and creates a "sur place (non-progressive) movement" inside the large intestine. Usually, the amoeba is immobile, and keeps its round shape. This amoeba, in its trophozoite stage, is only visible in fresh, unfixed stool specimens. Sometimes the Entamoeba coli have parasites as well. One is the fungus Sphaerita spp. This fungus lives in the cytoplasm of the E. coli. While this differentiation is typically done by visual examination of the parasitic cysts via light microscopy, new methods using molecular biology techniques have been developed. The scientific name of the amoeba, E. coli, is often mistaken for the bacterium, Escherichia coli. Unlike the bacterium, the amoeba is mostly harmless, and does not cause as many intestinal problems as some strains of the E. coli bacterium. To make the naming of these organisms less confusing, "alternate contractions" are used to name the species for the purpose making the naming easier; for example, using Esch. coli and Ent. coli for the bacterium and amoeba, instead of using E. coli for both.
Naegleria is a genus consisting of 47 described species of protozoa often found in warm aquatic environments as well as soil habitats worldwide. It has three life cycle forms: the amoeboid stage, the cyst stage, and the flagellated stage, and has been routinely studied for its ease in change from amoeboid to flagellated stages. The Naegleria genera became famous when Naegleria fowleri, the causative agent of the usually fatal human and animal disease primary amoebic meningoencephalitis (PAM), was discovered in 1965. Most species in the genus, however, are incapable of causing disease.
Stenotrophomonas maltophilia is an aerobic, nonfermentative, Gram-negative bacterium. It is an uncommon bacterium and human infection is difficult to treat. Initially classified as Bacterium bookeri, then renamed Pseudomonas maltophilia, S. maltophilia was also grouped in the genus Xanthomonas before eventually becoming the type species of the genus Stenotrophomonas in 1993.
Lincosamides are a class of antibiotics, which include lincomycin, clindamycin, and pirlimycin.
Antiprotozoal agents is a class of pharmaceuticals used in treatment of protozoan infection.
Pneumocystis pneumonia (PCP), also known as Pneumocystis jirovecii pneumonia (PJP), is a form of pneumonia that is caused by the yeast-like fungus Pneumocystis jirovecii.
Saccharomyces boulardii is a tropical yeast first isolated from lychee and mangosteen peels in 1923 by French scientist Henri Boulard. Although early reports claimed distinct taxonomic, metabolic, and genetic properties, S. boulardii is a grouping of S. cerevisiae strains, all sharing a >99% genomic relatedness. This has given rise to the synonym S. cerevisiae var. boulardii.
Blastocystis is a genus of single-celled parasites belonging to the Stramenopiles that includes algae, diatoms, and water molds. There are several species, living in the gastrointestinal tracts of species as diverse as humans, farm animals, birds, rodents, reptiles, amphibians, fish, and cockroaches. Blastocystis has low host specificity, and many different species of Blastocystis can infect humans, and by current convention, any of these species would be identified as Blastocystis hominis.
The discovery of disease-causing pathogens is an important activity in the field of medical science. Many viruses, bacteria, protozoa, fungi, helminths, and prions are identified as a confirmed or potential pathogen. In the United States, a Centers for Disease Control and Prevention program, begun in 1995, identified over a hundred patients with life-threatening illnesses that were considered to be of an infectious cause but that could not be linked to a known pathogen. The association of pathogens with disease can be a complex and controversial process, in some cases requiring decades or even centuries to achieve.
Blastocystosis refers to a medical condition caused by infection with Blastocystis. Blastocystis is a protozoal, single-celled parasite that inhabits the gastrointestinal tracts of humans and other animals. Many different types of Blastocystis exist, and they can infect humans, farm animals, birds, rodents, amphibians, reptiles, fish, and even cockroaches. Blastocystosis has been found to be a possible risk factor for development of irritable bowel syndrome.
Cardiobacterium hominis /ˌkɑːrdiəʊbækˈtɪəriəm ˈhɒmɪnɪs/ is a microaerophilic, pleomorphic, fastidious, Gram-negative bacterium part of the Cardiobacteriaceae family and the HACEK group. It is most commonly found in the human microbiota, specifically the oropharyngeal region including the mouth and upper part of the respiratory tract. It is one of the causes of endocarditis, a life-threatening inflammation close to the heart's inner lining and valves. While infections caused by Cardiobacterium hominis are uncommon, various clinical manifestations are linked to the bacterium, including meningitis, sepsis, and bone infections.
Entamoeba polecki is an intestinal parasite of the genus Entamoeba. E. polecki is found primarily in pigs and monkeys and is largely considered non-pathogenic in humans, although there have been some reports regarding symptomatic infections of humans. Prevalence is concentrated in New Guinea, with distribution also recorded in areas of southeast Asia, France, and the United States.
Cartazolate (SQ-65,396) is a drug of the pyrazolopyridine class. It acts as a GABAA receptor positive allosteric modulator at the barbiturate binding site of the complex and has anxiolytic effects in animals. It is also known to act as an adenosine antagonist at the A1 and A2 subtypes and as a phosphodiesterase inhibitor. Cartazolate was tested in human clinical trials and was found to be efficacious for anxiety but was never marketed. It was developed by a team at E.R. Squibb and Sons in the 1970s.
In biology, a pathogen, in the oldest and broadest sense, is any organism or agent that can produce disease. A pathogen may also be referred to as an infectious agent, or simply a germ.
Naegleria fowleri, also known as the brain-eating amoeba, is a species of the genus Naegleria. It belongs to the phylum Percolozoa and is classified as an amoeboflagellate excavate, an organism capable of behaving as both an amoeba and a flagellate. This free-living microorganism primarily feeds on bacteria but can become pathogenic in humans, causing an extremely rare, sudden, severe, and almost always fatal brain infection known as naegleriasis or primary amoebic meningoencephalitis (PAM).
Chilomastix is a genus of pyriform excavates within the family Retortamonadidae All species within this genus are flagellated, structured with three flagella pointing anteriorly and a fourth contained within the feeding groove. Chilomastix also lacks Golgi apparatus and mitochondria but does possess a single nucleus. The genus parasitizes a wide range of vertebrate hosts, but is known to be typically non-pathogenic, and is therefore classified as harmless. The life cycle of Chilomastix lacks an intermediate host or vector. Chilomastix has a resistant cyst stage responsible for transmission and a trophozoite stage, which is recognized as the feeding stage. Chilomastix mesnili is one of the more studied species in this genus due to the fact it is a human parasite. Therefore, much of the information on this genus is based on what is known about this one species.